Everything below concerns LC-MS/MS. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-11-13. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
==== Antiquity ==== Yavne was one of the major ancient cities in the southern coastal plain, situated 20 km (12.43 mi) south of Jaffa, 15 km (9.32 mi) north of Ashdod, and 7 km (4.35 mi) east of the Mediterranean. From excavations of the ancient tell (mound created by accumulation of archaeological remains) known as Tel Yavne (Hebrew), which developed on a natural kurkar hill, the area shows to have been inhabited continuously from either the Bronze or Iron Age until the British Mandate. During some periods, especially the Byzantine period, the settlement expanded to cover part of the plain and hills surrounding the tell. Yavne is mentioned in the Bible and other ancient texts. In Roman times, the city was known as Iamnia or Jamnia. It was bequeathed by King Herod upon his death to his sister Salome. Upon her death it passed to Emperor Augustus, who ran it as a private imperial estate, a status retained for at least a century. After Salome's death, Iamnia came into the property of Livia, the future Roman empress, and then to her son Tiberius. In the 40s AD, a dispute emerged in Jamnia when Gentiles constructed a mud-brick altar to the Emperor, provoking the local Jewish population. The Jews destroyed the altar, which they saw as desecration. This led the Gentiles to complain to Capito, the imperial revenue collector in Judaea, who reported the matter to Emperor Caligula. In retaliation, Caligula ordered a statue of himself as Jupiter to be placed in the Holy of Holies at the Temple of Jerusalem. Iamnia played a role in several events during the First Jewish–Roman War.
=== Biochemical function === Methylglyoxal is involved in the formation of advanced glycation end products (AGEs). In this process, methylglyoxal reacts with free amino groups of lysine and arginine and with thiol groups of cysteine forming AGEs. Argpyrimidine is one example. Histones are also heavily susceptible to modification by methylglyoxal and these modifications are elevated in breast cancer.
This should be able to happen in prebiotically plausible conditions with high rates of copying accuracy to prevent degradation of information, but also allowing for the occurrence of occasional errors during the copying process to allow for Darwinian evolution to proceed. Attempts have been made to develop ribozymes as therapeutic agents, as enzymes which target defined RNA sequences for cleavage, as biosensors, and for applications in functional genomics and gene discovery.
== Reported incidents == In 2017 the BBC reported a case in which a male hedgehog was "almost twice its natural size, literally blown up like a beach ball with incredibly taut skin". The head vet at Stapeley's Wildlife Hospital, Bev Panto, said, "In my career I have seen three or four of these cases and they are very strange every time and quite shocking [...] When you first see them they appear to be very big hedgehogs but when you pick them up they feel so light because they are mostly air". She added that the condition was unique to hedgehogs because they have significant space under their skin as a result of their ability to curl up. A similar case had been reported in 2013. In 2024, a hedgehog that was spotted by a passing bus passenger "swollen to the size of a football" was successfully deflated by rescuers in Gloucestershire.
Sources: en.wikipedia.org
Oligonucleotides are composed of 2'-deoxyribonucleotides (oligodeoxyribonucleotides), which can be modified at the backbone or on the 2' sugar position to achieve different pharmacological effects. These modifications give new properties to the oligonucleotides and make them a key element in antisense therapy.
Pierre Vanderbilt, a witch, reprising her role from Apocalypse Frances Conroy as Myrtle Snow, a witch, reprising her role from Coven and Apocalypse Joey Pollari as Benjamin "Ben" DeSoto, a hospice caretaker with triskaidekaphobia Jessica Lange as: Constance Langdon, Tate and Adelaide's mother, reprising her role from Murder House and Apocalypse Sister Jude Martin, a Briarcliff patient and former head nun in charge, reprising her role from Asylum Fiona Goode, the former Supreme of the witch Coven, reprising her role from Coven Elsa Mars, a manager of a freak show, reprising her role from Freak Show Margaret Thatcher, a former Prime Minister of the United Kingdom
=== One-Pot Synthesis === One-pot reactions involve combining all reactants simultaneously under appropriate conditions. This straightforward approach has proven successful for many simpler cage structures, particularly those formed through imine condensation. The success of one-pot synthesis often depends on the reversible nature of bond formation, allowing the system to self-correct and converge on the thermodynamically favored product. The reaction conditions, such as temperature, solvent choice, and concentration, play crucial roles in determining the outcome. For example, in imine cage synthesis, polar aprotic solvents like dichloromethane or chloroform are often preferred as they facilitate imine formation while allowing the removal of water byproduct. Additionally, techniques such as slow addition of components or temperature control can be employed to enhance selectivity towards the desired cage product.
Grameen Danone Foods, popularly known as Grameen Danone, is a social business enterprise, launched in 2006, which has been designed to provide children with many of the key nutrients that are typically missing from their diet in rural Bangladesh. It is run on 'No loss, No dividend' basis. Initially, Grameen Danone agreed to pay an annual dividend of one percent to shareholders, however, in December 2009, the board of Grameen Danone agreed to waive any monetary return.
Yeast taxonomy includes classification of yeast species depending on the presence or absence of a sexual phase. Therefore, some winemaking yeasts are classified by their asexual anamorph (or "imperfect" form) while others may be classified by their sexual teleomorph (or "perfect" form). A common example of this is Brettanomyces (or "Brett") that is usually referenced in wine and viticulture text under its asexual classification though some scientific and winemaking texts may describe specific species (such as Dekkera bruxellensis) under its sporulating sexual classification of Dekkera. Unless otherwise noted, this article will commonly refer to the asexual form of wine yeast. The most common yeast generally associated with winemaking is Saccharomyces cerevisiae which is also used in bread making and brewing. Other genera of yeast that can be involved in winemaking (either beneficially or as the cause of potential wine faults) include:
Sources: en.wikipedia.org
Electronic toll collection – on toll roads, an alternative to manual collection of tolls at a toll booth, in which a transponder in a vehicle, when triggered by a roadside transmitter, transmits a signal to a roadside receiver to register the vehicle's use of the road, enabling the owner to be billed for the toll.
The most common vehicle currently used for targeted drug delivery is the liposome. Liposomes are non-toxic, non-hemolytic, and non-immunogenic even upon repeated injections; they are biocompatible and biodegradable and can be designed to avoid clearance mechanisms (reticuloendothelial system (RES), renal clearance, chemical or enzymatic inactivation, etc.) Lipid-based, ligand-coated nanocarriers can store their payload in the hydrophobic shell or the hydrophilic interior depending on the nature of the drug/contrast agent being carried. The only problem to using liposomes in vivo is their immediate uptake and clearance by the RES system and their relatively low stability in vitro. To combat this, polyethylene glycol (PEG) can be added to the surface of the liposomes. Increasing the mole percent of PEG on the surface of the liposomes by 4-10% significantly increased circulation time in vivo from 200 to 1000 minutes. PEGylation of the liposomal nanocarrier elongates the half-life of the construct while maintaining the passive targeting mechanism that is commonly conferred to lipid-based nanocarriers. When used as a delivery system, the ability to induce instability in the construct is commonly exploited allowing the selective release of the encapsulated therapeutic agent in close proximity to the target tissue/cell in vivo. This nanocarrier system is commonly used in anti-cancer treatments as the acidity of the tumour mass caused by an over-reliance on glycolysis triggers drug release.
. The technique was first reported by Beckey in 1969. It is also the first ionization method to ionize nonvolatile and thermally labile compounds. One major difference of FD with other ionization methods is that it does not need a primary beam to bombard a sample.
In April 2000, Valve acquired the rights to the fan-made modification Counter-Strike. After some cooperation between the original team and Valve's developers, Valve sold the game in retail, retitled Half-Life: Counter-Strike. Set in various locations around the world with little connection to the events of the main Half-Life story, the game is a multiplayer shooter in which players assume the roles of members of combating teams of the governmental counter-terrorist forces and various terrorist militants opposing them. Due to originally being a mod of Half-Life, the game shared several assets with the 1998 game, including Black Mesa containers, vehicles and scientists, with the Black Mesa logos visible in several maps in the retail version implicitly setting them in the same universe. It was bundled with Half-Life in many subsequent packages, including Half-Life: Platinum Pack and Half-Life: Platinum. When Half-Life: Counter-Strike was remade as Counter-Strike: Source, it was bundled in all retail versions of Half-Life 2, as well as all of the initial digital versions. Some game journalists referred to it as "Half-Life 2's multiplayer version." Both the standard retail edition and the Bronze digital edition of Half-Life 2 came with Counter-Strike: Source, while the retail Collector's Edition and the digital Gold edition also included Day of Defeat: Source and Half-Life: Source.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.